Role of Interferon-Gamma (Ifn-γ) in Immune Response Regulation in Hiv-1 and Hiv-1 + Mycobacterium Tuberculosis (Tb) Infected Patients / Interferona-gamma (Ifn-γ) Loma Imūnās Atbildes Regulēšanā Pacientiem Ar HIV-1 un HIV-1 + mycobacterium Tuberculosis

Anonymous (2013). Open Source Epidemiologic Statistic for Public Health. Available at: http://www.openepi.com/v37/Menu/OE_Menu.htm (accessed 25.11.2013).Search in Google Scholar

Chen, K., Kolls, J. K. (2013). T Cell-Mediated Host Immune Defenses in the Lung. Ann. Rev. Immunol., 31, 605-633.10.1146/annurev-immunol-032712-100019Search in Google Scholar

Cheng, S. M., Li, J. C. B., Lin, S. S., Lee, D. C. W., Liu, L., Chen, Z., Lau, A. S. Y. (2009). HIV-1 transactivator protein induction of suppressor cytokine signaling-2 contributes to dysregulation of IFN-g signaling. Blood, 13, 5192-5201.10.1182/blood-2008-10-183525Search in Google Scholar

Getahun, H., Gunneberg, C., Granich, R., Nunn, P. (2010). HIV infection- associated tuberculosis: The epidemiology and the response. Clin. Infect. Dis., 50 (Suppl. 3), S201-S207.10.1086/651492Search in Google Scholar

Boekhoudt, G. H., McGrath, A. G., Swisher, J. F., Feldman, G. M. (2015). Immune complexes suppress IFN-γ-induced responses in monocytes by activating discrete members of the SRC kinase family. J. Immunol., 194 (3), 983-989.10.4049/jimmunol.1401649Search in Google Scholar

Klein, S. A., Dobmeyer, J. M., Dobmeyer, T. S., Pape, M., Ottmann, O. G., Helm, E. B., Hoelzer, D., Rossol, R. (1997). Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS, 11, 1111-1118.10.1097/00002030-199709000-00005Search in Google Scholar

Li, J. C. B., Au, K., Fang, J., Yim, H. C. H., Chow, K., Ho, P., Lau, A. S. Y. (2011). HIV-1 trans-activator protein dysregulates IFN-g signaling and contributes to the suppression of autophagy induction. AIDS, 25, 15-25.10.1097/QAD.0b013e328340fd61Search in Google Scholar

Modjarrad, K., Vermund, S. H. (2010). Effect of treating co-infections on HIV-1 viral load: A systematic review. Lancet Infect. Dis., 10, 455-463.10.1016/S1473-3099(10)70093-1Search in Google Scholar

Moller, M., Hoal, E. G. (2010). Current findings, challenges and novel approaches inhuman genetic susceptibility to tuberculosis. Tuberculosis (Edinburg), 90, 71-83.10.1016/j.tube.2010.02.00220206579Search in Google Scholar

Osakwe, C. E., Bleotu, C., Chifiriuc, M. C., Crancea, C., Otelea, D., Paraschiv, S., Petrea, S., Dinu, M., Baicus, C., Streinu-Cercel, A., Lazar, V. (2010). TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy. Roum. Arch. Microbiol. Immunol., 69 (1), 24-34.Search in Google Scholar

Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., Källenius, G. (2012). Tuberculosis and HIV co-infection. PLoS Pathog., 8 (2), e1002464.10.1371/journal.ppat.1002464328097722363214Search in Google Scholar

Roff, S. R, Noon-Song, E. N., Yamamoto, J. K. (2013). The significance of interferon-g in HIV-1 pathogenesis, therapy, and prophylaxis. Frontiers Immunol., 4, 498. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888948/ (accessed 20.05.2016).Search in Google Scholar

Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., Friedland, G. H. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl. J. Med., 320, 545-555.10.1056/NEJM1989030232009012915665Search in Google Scholar

Spellberg, B., Edwards, J. E., Jr. (2001). Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis., 32 (1), 76-102.10.1086/31753711118387Search in Google Scholar

Young, H. A., Hardy, K. J. (1995). Role of interferon-gamma in immune cell regulation. J. Leukocyte Biol., 58 (4), 373-381.10.1002/jlb.58.4.373Search in Google Scholar

Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., Eller, J. (1995). Accelerated course of human immunodeficiency virus infection after tuberculosis. Amer. J. Respir. Crit. Care Med., 151, 129-135.10.1164/ajrccm.151.1.78125427812542Search in Google Scholar